CRITICAL LIMB ISCHAEMIA WITH SPECIAL EMPHASIS ON EPIDEMIOLOGY, INFLAMMATORY MARKERS AND CARDIAC FUNCTION

Jamal Barani

Research output: ThesisDoctoral Thesis (compilation)

Abstract

In Conclusion

Paper I. In patients undergoing aorto-iliac angiography, no effects of the procedure

were seen upon inflammatory mediators. On the other hand, angiography influenced

markers of platelet activation in these patients.

Paper II. The incidence of CLI in southern Sweden is 38/100 000 subjects/year.

Both medical risk factors for atherosclerosis and concomitant cardiovascular disease

are common among patients with CLI. Furthermore, medical risk-factor

treatment in these high-risk patients is suboptimal in relation to current recommendations.

Patients with CLI need to be evaluated and treated by physicians with

knowledge of and interest for treatment of risk factors for atherosclerosis.

Papers III-IV. Of Swedish CLI patients, 24 % die during the first year after

hospitalisation. Inflammatory markers, especially neopterin and TNF-?, independently

predict 1-year mortality in CLI, and are related to indices of cardiac dysfunction.

Paper V. Diabetes in CLI is often combined with renal impairment and more

often with infra-inguinal atherosclerosis. The inflammatory markers TNF-? and

neopterin are increased in diabetic patients with CLI as compared to non-diabetic

patients with CLI.
Original languageEnglish
QualificationDoctor
Awarding Institution
  • Department of Clinical Sciences, Malmö
Supervisors/Advisors
  • Gottsäter, Anders, Supervisor
Award date2006 Jun 9
Publisher
ISBN (Print)91-85481-64-5
Publication statusPublished - 2006

Bibliographical note

Defence details

Date: 2006-06-09
Time: 09:00
Place: Lilla Aulan vid Medicinskt forskingscentrum, ingång 59, Universitetssjukhuset MAS, Malmö

External reviewer(s)

Name: Björck, Martin
Title: Docent
Affiliation: Kärlkirurgisk kliniken, Akademiska Sjukhuset, Uppsala

---


<div class="article_info">J Barani, A Gottsäter, I Mattiasson and B Lindblad. <span class="article_issue_date">2002</span>. <span class="article_title">Platelet and leukocyte activation during aortoiliac angiography and angioplasty.</span> <span class="journal_series_title">Eur J Vasc Endovasc Surg</span>, <span class="journal_volume">vol 23</span> <span class="journal_pages">pp 220-225</span>.</div>
<div class="article_info">J Barani, I Mattiasson, B Lindblad and A Gottsäter. <span class="article_issue_date">2005</span>. <span class="article_title">Suboptimal treatment of risk factors for atherosclerosis in critical limb ischaemia.</span> <span class="journal_series_title">24</span>, </div>
<div class="article_info">J Barani, JÅ Nilsson, I Mattiasson, B Lindblad and A Gottsäter. <span class="article_issue_date">2005</span>. <span class="article_title">Inflammatory mediators are associated with 1-year mortality in critical limb ischaemia.</span> <span class="journal_series_title">42</span>, </div>
<div class="article_info">J Barani, I Mattiasson, B Lindblad and A Gottsäter. <span class="article_issue_date">2006</span>. <span class="article_title">Cardiac function related to inflammatory mediators and one-year mortality in critical limb ischaemia.</span> <span class="journal_series_title">Angiology</span>, (inpress)</div>
<div class="article_info">L Bertz, J Barani, A Gottsäter, PM Nilsson, I Mattiasson and B Lindblad. <span class="article_issue_date"></span>. <span class="article_title">Inflammatory markers in patients with critical limb ischaemia: Differences between diabetic and non-diabetic patients.</span> (submitted)</div>

Subject classification (UKÄ)

  • Clinical Medicine

Free keywords

  • Risk factors.
  • Peripheral arterial disease.
  • Medicin (människa och djur)
  • Medicine (human and vertebrates)
  • Critical limb ischaemia.
  • inflammatory markers.
  • Mortality.
  • Congestive heart failure.

Fingerprint

Dive into the research topics of 'CRITICAL LIMB ISCHAEMIA WITH SPECIAL EMPHASIS ON EPIDEMIOLOGY, INFLAMMATORY MARKERS AND CARDIAC FUNCTION'. Together they form a unique fingerprint.

Cite this